Literature DB >> 977619

Prevention of venous thromboembolism in orthopaedic patients.

E W Salzman, W H Harris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 977619

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


× No keyword cloud information.
  16 in total

1.  Orthopaedic surgeons and thromboprophylaxis.

Authors:  M D Laverick; S A Croal; R A Mollan
Journal:  BMJ       Date:  1991-09-07

Review 2.  Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.

Authors: 
Journal:  BMJ       Date:  1992-09-05

3.  Joint replacement in the elderly.

Authors:  T P Sculco; S E Powell
Journal:  Bull N Y Acad Med       Date:  1987-03

4.  Risks and benefits of elective hip replacement in the octogenarian.

Authors:  T W Phillips; R W Grainger; H S Cameron; L Bruce
Journal:  CMAJ       Date:  1987-09-15       Impact factor: 8.262

Review 5.  Failure patterns after total hip replacement.

Authors:  J E Nixon
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-15

6.  Prophylaxis of venous thromboembolism: analysis of cost effectiveness.

Authors:  E W Salzman; G C Davies
Journal:  Ann Surg       Date:  1980-02       Impact factor: 12.969

7.  Deep vein thrombosis and anaesthetic technique in emergency hip surgery.

Authors:  F M Davis; M Quince; V G Laurenson
Journal:  Br Med J       Date:  1980-12-06

8.  Comparative value of tests for the diagnosis of venous thrombosis.

Authors:  J Hirsh; R Hull
Journal:  World J Surg       Date:  1978-01       Impact factor: 3.352

9.  Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.

Authors:  P F Leyvraz; F Bachmann; J Hoek; H R Büller; M Postel; M Samama; M D Vandenbroek
Journal:  BMJ       Date:  1991-09-07

10.  Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.

Authors: 
Journal:  Arch Orthop Trauma Surg       Date:  1992       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.